Header

UZH-Logo

Maintenance Infos

Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance


Meyer Sauteur, Patrick M; van Rossum, Annemarie M C; Vink, Cornelis (2014). Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Current Opinion in Infectious Diseases, 27(3):220-227.

Abstract

PURPOSE OF REVIEW
Both the diagnosis and treatment of Mycoplasma pneumoniae infections in children are currently facing two main challenges: a relatively high carriage in asymptomatic children, and a worldwide increase in macrolide-resistant M. pneumoniae (MRMP). This review focuses on the scientific and clinical implications of these crucial issues.
RECENT FINDINGS
Recent studies have indicated that the prevalence of M. pneumoniae in the upper respiratory tract is similar among asymptomatic, healthy children and children with a symptomatic respiratory tract infection, and that current diagnostic procedures for M. pneumoniae are unable to differentiate between bacterial carriage and infection. It is therefore possible that the burden of M. pneumoniae-associated disease is overestimated. Another phenomenon that has an important impact on the treatment of M. pneumoniae infections is the rapid worldwide emergence of MRMP isolates.
SUMMARY
The current diagnostic procedures for M. pneumoniae cannot discern between bacterial carriage and infection in a clinically relevant time frame. It is therefore imperative that these procedures be modified such as to unambiguously detect symptomatic M. pneumoniae infections. Moreover, the emergence of MRMP necessitates the application of methods to detect macrolide resistance as well as the implementation of restrictive policies regarding the use of macrolides.

Abstract

PURPOSE OF REVIEW
Both the diagnosis and treatment of Mycoplasma pneumoniae infections in children are currently facing two main challenges: a relatively high carriage in asymptomatic children, and a worldwide increase in macrolide-resistant M. pneumoniae (MRMP). This review focuses on the scientific and clinical implications of these crucial issues.
RECENT FINDINGS
Recent studies have indicated that the prevalence of M. pneumoniae in the upper respiratory tract is similar among asymptomatic, healthy children and children with a symptomatic respiratory tract infection, and that current diagnostic procedures for M. pneumoniae are unable to differentiate between bacterial carriage and infection. It is therefore possible that the burden of M. pneumoniae-associated disease is overestimated. Another phenomenon that has an important impact on the treatment of M. pneumoniae infections is the rapid worldwide emergence of MRMP isolates.
SUMMARY
The current diagnostic procedures for M. pneumoniae cannot discern between bacterial carriage and infection in a clinically relevant time frame. It is therefore imperative that these procedures be modified such as to unambiguously detect symptomatic M. pneumoniae infections. Moreover, the emergence of MRMP necessitates the application of methods to detect macrolide resistance as well as the implementation of restrictive policies regarding the use of macrolides.

Statistics

Citations

Dimensions.ai Metrics
28 citations in Web of Science®
26 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 08 Feb 2019
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, not_refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:June 2014
Deposited On:08 Feb 2019 11:10
Last Modified:25 Sep 2019 00:05
Publisher:Lippincott Williams & Wilkins
ISSN:0951-7375
OA Status:Closed
Publisher DOI:https://doi.org/10.1097/QCO.0000000000000063
PubMed ID:24751894

Download